欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号CZ/H/1010/003
药品名称Sitagliptin Zentiva
活性成分
    • Sitagliptin Hydrochloride monohydrate 100.0 mg
剂型Film-coated tablet
上市许可持有人Zentiva, k.s. U kabelovny 130 10237, Praha 10 - Dolní Měcholupy Czech Republic
参考成员国 - 产品名称Czechia (CZ)
Sitagliptin Zentiva
互认成员国 - 产品名称
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
      Sitagliptin Zentiva
    • Denmark (DK)
    • Iceland (IS)
      Sitagliptin Zentiva
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
许可日期2021/11/03
最近更新日期2024/08/29
药物ATC编码
    • A10BH01 sitagliptin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase